Inflammatory bowel disease: a Canadian burden of illness review - Wikidata - wikimedia - TriplyDB

Inflammatory bowel disease: a Canadian burden of illness review

Inflammatory bowel disease: a Canadian burden of illness review

http://www.wikidata.org/entity/Q36391797

about

A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease Selective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumab Animal models to study acute and chronic intestinal inflammation in mammals Capsule Endoscopy in the Assessment of Obscure Gastrointestinal Bleeding: An Economic Analysis Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn's disease: a systematic review and clinician surveys Estimated economic benefit of increasing 25-hydroxyvitamin D concentrations of Canadians to or above 100 nmol/L Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article The burden of inflammatory bowel disease in Europe Distance management of inflammatory bowel disease: systematic review and meta-analysis The incidence of ulcerative colitis (1995-2011) and Crohn's disease (1995-2012) - based on nationwide Danish registry data.Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial.Estimates of Disease Course in Inflammatory Bowel Disease Using Administrative Data: A Population-level Study.High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.Dietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort study.Validation of an internet-based cohort of inflammatory bowel disease (CCFA partners).DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis.Perturbation of the human microbiome as a contributor to inflammatory bowel disease Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe.Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey.Predictors of ICU Admission and Outcomes 1 Year Post-Admission in Persons with IBD: A Population-based Study.Combination therapy for the treatment of Crohn's disease.Ulcerative Colitis: Update on Medical Management.A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease Claims for disease-modifying therapy by Alberta non-insured health benefits clients.Ulcerative colitis-associated hospitalization costs: a population-based study The Challenges of Living with Inflammatory Bowel Disease: Summary of a Summit on Patient and Healthcare Provider Perspectives Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.Employment prospects and trends for gastroenterology trainees in Canada: a nationwide survey.Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age.Patient-Reported Outcomes Measurement Information System in Children with Crohn's Disease.Metastatic Crohn's Disease: An Approach to an Uncommon but Important Cutaneous Disorder.Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications.The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model.Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease.Aseptic Abscesses and Inflammatory Bowel Disease: Two Cases and Review of Literature.Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement on subsequent entry biologics.Cellular and Molecular Mediators of Intestinal Fibrosis.Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey.The global burden of IBD: from 2015 to 2025.

P2860

Q26750421-0FC01673-8B9E-4405-9825-989156E14F81 Q26750456-3A277456-AEF1-4D5A-B914-A09C687F253C Q26777430-043C1302-C222-4919-826D-5350130D15D1 Q26781952-D3EBD78C-DA24-4630-9FAB-842CC6E0204F Q26862821-C747DF35-454C-47FF-8D26-41EC6B8BBA24 Q28069109-E8E456F3-B332-4BD9-8143-EF9837A5C22E Q28076892-56DCC592-A7F4-4A34-9F40-C2ECB256F9CD Q28285200-7918A89E-9899-4641-BBD7-9C9CDED5964A Q30486789-70A1E1CB-1238-4724-9247-B56D659112FA Q30787053-E63C7D07-CD66-4BDE-AB3E-346BA8E07119 Q31115615-36067A64-AE70-4938-9A18-D8D384E27FF9 Q31141014-39122CCE-F7EF-42DC-BB85-024B4AD04CE7 Q33674784-91ED1542-1663-4767-B01D-32ECF22DFC78 Q33786052-F6060B6C-87E8-441A-BE23-CF32C673D8BF Q33956984-85837BB1-03F2-4207-AC26-4A9F5EE1D1BA Q34183403-EBEF21A8-AC29-47BA-B1E2-0E592507255A Q34569117-D181B82E-67F8-4097-B4A2-1F81DCA54308 Q35012080-AC49D1C9-A1B7-4ECA-9794-5F07F0269D09 Q35069447-70891C11-6FA8-4F72-AAEE-46AF2D7AE147 Q35216610-2B0B9D10-48A6-44FF-B0F1-D0ADFA5B3F27 Q35670649-3C299FDA-1DB9-40B7-BBEE-798FE1B54991 Q35714202-BC05E816-04F8-41D2-B511-F26400D05386 Q35781294-DE2A7AE0-5B8A-4327-9CAC-371035FCD126 Q35973766-92F73095-1280-47EC-8AD9-E7E1266FAD77 Q36112027-B250500B-B643-4672-93D8-C89D151BA77D Q36176470-F9973669-7673-41EB-9410-42C30CE1FA4D Q36997039-9776F8CC-82AA-46B3-BC4B-33C602E16B61 Q37118397-FA779D46-814F-44A7-99A5-C90FDA4A5527 Q37278354-EDC08C7F-E085-4A86-A499-C15D4A72F1A6 Q37448471-B8784E4D-79AB-4A64-AFC7-B531F1BE2941 Q37505022-DA9B4D5C-CAD1-42E7-B279-84B663C5B01E Q37588715-9D0FE702-FBFF-439E-B7E1-F3681ED8D840 Q37597661-34E4D7FE-E2BD-49E0-ADEA-BE7A306D3004 Q37599087-F17B4826-D361-4E0A-AC36-AABB63A172A3 Q37604067-8F84079C-39A4-4A33-9574-067366F8DC07 Q37652551-07A5E725-FA1E-4B37-B7CD-78157761447C Q38150859-4587A995-116D-49FD-9617-4A76DF151A39 Q38259227-4DA4172C-288C-4D67-A26F-11E72DF122D0 Q38525815-F47F9B8F-DF96-4DB5-B89E-D4DA2DE66B35 Q38577572-DAD8E799-16E7-4348-A5BA-F7571065D3AC

P2860

Inflammatory bowel disease: a Canadian burden of illness review

http://www.wikidata.org/entity/Q36391797

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Inflammatory bowel disease: a Canadian burden of illness review

@ast

Inflammatory bowel disease: a Canadian burden of illness review

@en

type

label

Inflammatory bowel disease: a Canadian burden of illness review

@ast

Inflammatory bowel disease: a Canadian burden of illness review

@en

prefLabel

Inflammatory bowel disease: a Canadian burden of illness review

@ast

Inflammatory bowel disease: a Canadian burden of illness review

@en

P1433

Q36391797-3A12E806-5941-41CB-8ACB-622BFC1EA62C

P1476

Q36391797-A92EBCF3-FD87-4910-9900-775DA399D137

P2093

Q36391797-35DE5A26-0215-49D9-8571-A4129033A61E

Q36391797-478085E7-A928-4ADB-9695-18358F2275E6

Q36391797-6EAE3B40-4C74-4EE2-9FAC-DEF6ADCDEECB

Q36391797-9333DD07-4791-47BE-88CD-30AE2F3EDD4E

Q36391797-BE77AD30-FD46-484F-937D-90DDFA34D391

Q36391797-FCC9AB2D-2AFB-4E26-96E6-6FCAA5E5E9E7

Q36391797-FD2230D4-1D9A-41B8-AE32-ACAEBD9A489A

P2860

Q36391797-08A69F0C-0312-4AB5-8975-4557FBFE8096

Q36391797-0BF2E9A1-454E-4FDC-BBD2-9575CCE44F5A

Q36391797-0F7397D9-2F01-4D48-A119-03884D7CCC7D

Q36391797-20E1C17C-C8C8-432B-A67F-2F0D9231667A

Q36391797-25A726C8-B851-4002-8E66-6D6DCB50E14D

Q36391797-27647DBF-1ED7-4477-AE22-89FC73B6CC20

Q36391797-27E834B0-5DF1-4344-B165-44C6DD650EC9

Q36391797-2A15FFA4-B2EE-47BA-A172-8E2F4BD89029

Q36391797-38DE4F2A-4364-41D2-BB2A-E74BF7DF2B20

Q36391797-3EB07987-859B-4026-8031-12FF04B97A70

P304

Q36391797-06FCC7E6-95ED-4A00-9678-913AAF203A0F

P31

Q36391797-0537C4CF-6783-4533-B067-EDD8B7EDE5FB

Q36391797-bb87fad2-bb7a-4c72-9115-15f3aca74e08

P356

Q36391797-DDD07273-DE2F-4A02-9732-ABB56465FD96

P407

Q36391797-04B5A708-2C19-4B69-892F-AF1BEFD3605A

P433

Q36391797-96426EE0-A95E-42F3-83D6-87D00222CD0F

P478

Q36391797-624C496E-E2DF-464A-8E04-2A85D7A4DEB9

P50

Q36391797-039C35F2-2804-40B1-A0E0-08306BA40018

Q36391797-FCBCFD3B-14CA-4546-A491-BC72FC777D01

P577

Q36391797-02733355-4B69-4995-A000-DD17824202FA

P5875

Q36391797-B52B9248-77A8-4D91-8880-C6947AE9CE51

P698

Q36391797-9904DB9F-D20A-4AD6-9D51-9256ED643525

P921

Q36391797-06EE1EED-1E13-49ED-A03F-B3A58206246E

Q36391797-F3616967-194E-43C8-BD27-C02941DB30D5

P932

Q36391797-AC09E02E-E95B-4FAA-8D41-1EA5B3263185

P356

P1433

Canadian Journal of Gastroenterology & Hepatology

P1476

Inflammatory bowel disease: a Canadian burden of illness review

@en

P2093

Aida Fernandes

http://www.w3.org/2001/XMLSchema#string

Alain Bitton

http://www.w3.org/2001/XMLSchema#string

Angela Rocchi

http://www.w3.org/2001/XMLSchema#string

Charles N Bernstein

http://www.w3.org/2001/XMLSchema#string

Kevin W Glasgow

http://www.w3.org/2001/XMLSchema#string

Remo Panaccione

http://www.w3.org/2001/XMLSchema#string

Subrata Ghosh

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

A national survey on the patterns of treatment of inflammatory bowel disease in Canada

Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data.

The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Meta-analysis: mortality in Crohn's disease.

Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis.

Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease.

Objective assessment of quality of life following panproctocolectomy and ileostomy for ulcerative colitis.

Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease.

Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends.

P304

811-817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/984575

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Eric I Benchimol

Brian G. Feagan

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233725831

http://www.w3.org/2001/XMLSchema#string

P698

23166905

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

3495699

http://www.w3.org/2001/XMLSchema#string